Illudent
San Diego, US · Delaware corporation · 1 known investors
Founders & leadership
MJ
Michael J. KelnerNamed on SEC filing
SL
Shaun LonerganNamed on SEC filing
Board
JG
CK
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 2 rounds · 2023–2025
▶$3.2MraisedAug 2025 · 11 investors · PharmaceuticalsRule 506(b)
▶$3.2MraisedAug 2025 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. KelnerExecutive Officer, Director
- Joe GattoExecutive Officer, Director
- Clint KorverDirector
- Offering amount
- $4M
- Amount sold
- $3.2M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedOct 2023 · 16 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedOct 2023 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joe GattoDirector
- Shaun LonerganDirector
- Michael J. KelnerExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Illudent's investors?
- Illudent's investors include Ulu Ventures.
- How much funding has Illudent raised?
- Illudent has disclosed $4.4M raised across 2 rounds.
- Where is Illudent headquartered?
- Illudent is headquartered in San Diego, US.